Navigation Links
Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
Date:7/30/2008

ture financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that we make are described in greater detail in the reports we file with Securities and Exchange Commission, including the "Risk Factors" section in Item 1 of the Form 10-KSB we filed with the Securities and Exchange Commission on March 27, 2008. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Global Announces Contract To Acquire New Business 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 1Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 2Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 3Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 4Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 5Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 6Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 7Miami LASIK Laser Eye Surgery Cataract Surgery Refractive Surgeon Expert Dr William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Di 13919 8CyberKnife Treatment for Medically Inoperable Lung Cancer 56512 1CyberKnife Treatment for Medically Inoperable Lung Cancer 56512 2Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family 56508 1Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family 56508 2
Other Medicine News:Health News:Hazelden Publishing Launches Parent Toolkit During National Bullying Prevention Awareness Week 2Health News:Dr. Oz and Dr. Roizen Prove That Aging Is Actually Reversible in You: Staying Young on Discovery Health 2Health News:Dr. Oz and Dr. Roizen Prove That Aging Is Actually Reversible in You: Staying Young on Discovery Health 3Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 2Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 3Health News:Harvard Medical School: Healthy Lifestyle Will Boost Your Immune System Better Than a Handful of Supplements 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 3Health News:Religion and healthcare should mix, MU study says 2